BCR and B-cell chronic lymphocytic leukemia: On the other hand, in the CLL microenvironment, when a cell carrying the intrinsically autonomous signaling-prone IGLV3-21*01/04 allele acquires the crucial R110 mutation, it experiences a survival advantage through autonomous BCR activation.